Physician

Ahila Lingappan, MD

According to 2025 Medicare claims, Ahila Lingappan, MD (NPI: 1336390624) practices ophthalmology in the Camden, NJ market, with the plurality of this provider's patient population coming from Camden, NJ. This provider's primary affiliated billing organization is EYE PHYSICIANS PC (NPI: 1063459931; TIN: 223393270) and primary practice location at 08080-9227.

Lingappan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,700 traditional Medicare patients, billed 3,451 HCPCS/CPT codes, and received $241,824 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 1,738 prescription claims across 687 beneficiaries totaling $508,560 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 5 records totaling $94. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $160,631 to $508,560. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$148K$296K2015 Medicare payment: $237,311 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $229,296 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $259,214 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $296,056 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $216,247 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $156,984 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $199,326 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $236,678 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $251,351 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $241,824 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,2482,494$237,311
20161,3462,688$229,296
20171,4862,952$259,214
20181,5393,241$296,056
20191,4592,891$216,247
20201,1522,193$156,984
20211,2732,613$199,326
20221,5353,249$236,678
20231,6483,416$251,351
20241,7003,451$241,824

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$254K$509K2015 Drug cost: $160,631 (USD; Tot_Drug_Cst)2016 Drug cost: $195,665 (USD; Tot_Drug_Cst)2017 Drug cost: $214,882 (USD; Tot_Drug_Cst)2018 Drug cost: $285,328 (USD; Tot_Drug_Cst)2019 Drug cost: $256,266 (USD; Tot_Drug_Cst)2020 Drug cost: $97,180 (USD; Tot_Drug_Cst)2021 Drug cost: $273,305 (USD; Tot_Drug_Cst)2022 Drug cost: $426,266 (USD; Tot_Drug_Cst)2023 Drug cost: $501,483 (USD; Tot_Drug_Cst)2024 Drug cost: $508,560 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153551,077$160,631
20163941,145$195,665
20174461,252$214,882
20185881,710$285,328
20195301,275$256,266
2020273505$97,180
20215261,265$273,305
20226231,552$426,266
20236541,655$501,483
20246871,738$508,560

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system255255$101
92014Established patient complete exam of visual system1,2221,388$89
92012Established patient problem focused exam of visual system481746$65
92134Imaging of retina245301$30
92133Imaging of optic nerve242249$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine1168,280$164,685
LumiganBimatoprost22012,958$114,489
CyclosporineCyclosporine645,340$61,314
XiidraLifitegrast231,770$37,685
VyzultaLatanoprostene Bunod432,192$19,635

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$94ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ahila Lingappan, MD?

Tedicare shows public-source Medicare data for Ahila Lingappan, MD (NPI 1336390624), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahila Lingappan, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ahila Lingappan, MD?

Ahila Lingappan, MD is linked to EYE PHYSICIANS PC (billing NPI 1063459931) in the available physician profile data.

Does Ahila Lingappan, MD have Open Payments data?

Ahila Lingappan, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.